Biomerica (BMRA) Amortization of Deferred Charges (2021 - 2026)
Biomerica (BMRA) reported Amortization of Deferred Charges of $85000.0 for Q1 2026, up 8.97% on a YoY basis from $78000.0 in Q1 2025, and up 2.41% sequentially from $83000.0 in Q4 2025.
Biomerica (BMRA) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Biomerica (BMRA) has 6 years of Amortization of Deferred Charges data on file, last reported at $85000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges rose 8.97% year-over-year to $85000.0; the trailing twelve-month figure through Feb 2026 stood at $331000.0 (up 7.82% YoY), and the FY2025 full-year result was $313000.0, up 6.83% from the prior year.
- Amortization of Deferred Charges grew to $85000.0 in Q1 2026, from $83000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $85000.0 in Q1 2026 to a low of $63657.0 in Q1 2022.
- A 5-year average of $73703.6 and a median of $74000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges slipped 1.97% in 2023 and increased 15.38% in 2024, its largest moves.
- Tracing BMRA's Amortization of Deferred Charges over 5 years: stood at $67000.0 in 2022, then advanced by 8.96% to $73000.0 in 2023, then rose by 6.85% to $78000.0 in 2024, then climbed by 6.41% to $83000.0 in 2025, then advanced by 2.41% to $85000.0 in 2026.
- Business Quant data shows BMRA's Amortization of Deferred Charges at $85000.0 in Q1 2026, $83000.0 in Q4 2025, and $82000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 85,000.00 |
| Feb 28, 2026 | 85,000.00 |
| Nov 30, 2025 | 83,000.00 |
| Nov 30, 2025 | 83,000.00 |
| Aug 31, 2025 | 82,000.00 |
| Aug 31, 2025 | 82,000.00 |
| May 31, 2025 | 81,000.00 |
| May 31, 2025 | 81,000.00 |
| Feb 28, 2025 | 78,000.00 |
| Feb 28, 2025 | 78,000.00 |
| Nov 30, 2024 | 78,000.00 |
| Nov 30, 2024 | 78,000.00 |
| Aug 31, 2024 | 76,000.00 |
| Aug 31, 2024 | 76,000.00 |
| May 31, 2024 | 75,000.00 |
| May 31, 2024 | 75,000.00 |
| Feb 29, 2024 | 74,000.00 |
| Feb 29, 2024 | 74,000.00 |
| Nov 30, 2023 | 73,000.00 |
| Nov 30, 2023 | 73,000.00 |